MA29587B1 - Compositions et methodes de diagnostic et de traitement de tumeur - Google Patents

Compositions et methodes de diagnostic et de traitement de tumeur

Info

Publication number
MA29587B1
MA29587B1 MA30347A MA30347A MA29587B1 MA 29587 B1 MA29587 B1 MA 29587B1 MA 30347 A MA30347 A MA 30347A MA 30347 A MA30347 A MA 30347A MA 29587 B1 MA29587 B1 MA 29587B1
Authority
MA
Morocco
Prior art keywords
diagnosis
treatment
methods
compositions
tumor
Prior art date
Application number
MA30347A
Other languages
English (en)
French (fr)
Inventor
Patrick Dowd
Gretchen Frantz
Paul Polakis
Victoria Smith
Susan Spencer
Thomas Wu
Zemin Zhang
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/102,501 external-priority patent/US20050272120A1/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MA29587B1 publication Critical patent/MA29587B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA30347A 2005-04-08 2007-10-30 Compositions et methodes de diagnostic et de traitement de tumeur MA29587B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/102,501 US20050272120A1 (en) 2001-06-20 2005-04-08 Compositions and methods for the diagnosis and treatment of tumor

Publications (1)

Publication Number Publication Date
MA29587B1 true MA29587B1 (fr) 2008-07-01

Family

ID=38667206

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30347A MA29587B1 (fr) 2005-04-08 2007-10-30 Compositions et methodes de diagnostic et de traitement de tumeur

Country Status (14)

Country Link
EP (1) EP1871886A2 (no)
JP (1) JP2008535498A (no)
KR (1) KR20080003405A (no)
CN (1) CN101208431A (no)
AU (1) AU2006235436A1 (no)
BR (1) BRPI0609729A2 (no)
CA (1) CA2604377A1 (no)
CR (1) CR9486A (no)
IL (1) IL185900A0 (no)
MA (1) MA29587B1 (no)
MX (1) MX2007012216A (no)
NO (1) NO20075698L (no)
RU (1) RU2007141407A (no)
ZA (1) ZA200707967B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201408598XA (en) * 2009-11-30 2015-02-27 Genentech Inc Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211 = seqid2 )
JP2015523852A (ja) * 2012-05-14 2015-08-20 ジェネンテック， インコーポレイテッド 腫瘍の診断と治療のための組成物と方法
EP3981426A4 (en) * 2019-06-06 2023-06-07 Denka Company Limited PEPTIDE NUCLEIC ACID ADJUVANT

Also Published As

Publication number Publication date
CA2604377A1 (en) 2006-10-19
MX2007012216A (es) 2007-12-06
KR20080003405A (ko) 2008-01-07
JP2008535498A (ja) 2008-09-04
ZA200707967B (en) 2008-11-26
CN101208431A (zh) 2008-06-25
IL185900A0 (en) 2008-01-06
RU2007141407A (ru) 2009-05-20
NO20075698L (no) 2008-01-07
AU2006235436A1 (en) 2006-10-19
CR9486A (es) 2008-02-20
EP1871886A2 (en) 2008-01-02
AU2006235436A2 (en) 2006-10-19
BRPI0609729A2 (pt) 2010-04-20

Similar Documents

Publication Publication Date Title
MA29615B1 (fr) Preparations et methodes pour le diagnostic et le traitement d'une tumeur
MA33839B1 (fr) Compositions et procédés destinés à diagnostiquer et à traiter des tumeurs
MA32226B1 (fr) Compositions et leurs procedes de preparation et d'utilisation
WO2006029183A3 (en) Compositions and methods for the diagnosis and treatment of tumor
EA200701799A1 (ru) Транс-каротиноиды, синтез указанных каротиноидов, получение композиций и их применение
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
MA33256B1 (fr) Anticorps et immunoconjugués anti-fcrh5 et procédés d'utilisation
MA28935B1 (fr) Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite
UY31114A1 (es) Anticuerpos humanizados contra el globulómero ab(20-42) y sus usos
AU2008298744A8 (en) MiRNA expression in human peripheral blood microvesicles and uses thereof
EA201201650A1 (ru) Связывающие молекулы человека, имеющие убивающую активность против стафилококков, и их применения
MA32351B1 (fr) Derives d'aminodihydrothiazine a titre d'inhibiteurs de bace pour le traitement de la maladie d'alzheimer
EA200802213A1 (ru) Способы лечения заболеваний крови
EA200870019A1 (ru) Лактамовые соединения и способы их применения
IL195256A0 (en) Compositions of r(+)and s(-)pramipexole and methods of using the same
ATE555814T1 (de) Radioaktive mittel für die in vivo pet-bildgebung von ccr5
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
MY172157A (en) Thioninium compounds and their use
MA31435B1 (fr) Inhibition de metastases tumorales par des anticoprs anti-neuropiline 2
WO2010033773A3 (en) Diagnostic, prognostic and therapeutic uses of mirs in adaptive pathways and/or disease pathways
ATE472998T1 (de) Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis
NO20071613L (no) Forbindelser for myokardial perfusjons-billeddannelse
ATE459600T1 (de) Substituierte pyrrolidin-2-one
NO20076405L (no) Anvendelse av 24-nor-UDCA
MA34291B1 (fr) Compositions et méthodes de diagnostic et de traitement d'une tumeur